Cite
HARVARD Citation
Ying, L. et al. (2018). (−)‐Epigallocatechin‐3‐gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells. Clinical and experimental pharmacology and physiology. pp. 58-67. [Online].